States are increasingly enacting price transparency laws designed to provide regulators or the public with more information about how entities in the drug distribution system set prices. The data visualization summarizes the 35 drug pricing transparency bills enacted in states between 2015 and 2018.
Other featured articles
Geographic Variation in the Delivery of High-Value Inpatient Care
Hospitals in Miami produced 13 percent fewer high-quality hospital stays than the U.S. average, while hospitals in Everett, Washington, a city 25 miles north of Seattle, perform over 20 percent better than average on value.
Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare Beneficiaries
The share of generic drugs that at least doubled in price increased fourfold according to the Health Affairs study. But, this share is still a small percentage of the generic market.
Reductions in Mid-Life Diabetes, Hypertension Increase Future Number of Americans with Dementia
Improving cardiovascular health at middle and older ages is not enough to slow the growth in the number of older Americans with dementia, further underscoring the need for innovations that will delay or prevent dementia.
Overpaying for Prescription Drugs: The Copay Clawback Phenomenon
In 2013, almost one quarter of filled pharmacy prescriptions (23%) involved a patient copayment that exceeded the average reimbursement paid by the insurer by more than $2.00.